| Literature DB >> 33237014 |
Gaurav Verma1, Bradley N Delman2, Priti Balchandani3.
Abstract
More than one million people in the United States suffer from seizures that are not controlled with antiseizure medications. Targeted interventions such as surgery and deep brain stimulation can confer seizure reduction or even freedom in many of these patients with drug-resistant epilepsy, but success critically depends on identification of epileptogenic zones through MR imaging. Ultrahigh field imaging facilitates improved sensitivity and resolution across many imaging modalities and may facilitate better detection of epileptic markers than is achieved at lower field strengths. The increasing availability and clinical adoption of ultrahigh field scanners play an important role in characterizing drug-resistant epilepsy and planning for its treatment.Entities:
Keywords: 7T; Epilepsy; MR imaging; Ultrahigh
Mesh:
Year: 2021 PMID: 33237014 PMCID: PMC8794037 DOI: 10.1016/j.mric.2020.09.006
Source DB: PubMed Journal: Magn Reson Imaging Clin N Am ISSN: 1064-9689 Impact factor: 2.266